Premium
DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS
Author(s) -
Lue J.K.,
Prabhu S.A.,
Liu Y.,
Verma A.,
Elemento O.,
Amengual J.E.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_120
Subject(s) - ezh2 , cancer research , prc2 , cell culture , acetylation , lymphoma , panobinostat , chemistry , microbiology and biotechnology , epigenetics , biology , histone , immunology , histone deacetylase , genetics , biochemistry , gene